247(top 1%)
PR articles
16.3K(top 1%)
PR citations
66(top 1%)
PR h-index
72(top 1%)
h-index
293
documents
22.8K
doc citations
3.2K
citing journals
100
times ranked

Publications

257 peer-reviewed articles • 18,308 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Critical menarche age for late-life dementia and the role of education and socioeconomic status1.63Citations (PDF)
2Accounting for access to healthcare: Analyzing interview talk of hard-to-reach regions’ residents and mobile medical units’ professionals in Greece
Journal of Health Psychology, 2025, 30, 1104-1119
2.60Citations (PDF)
3Diets to promote healthy brain ageing
Nature Reviews Neurology, 2025, 21, 5-16
28.633Citations (PDF)
4Inflammatory biomarkers profiles and cognition among older adults
Scientific Reports, 2025, 15,
3.414Citations (PDF)
5Can Sleep Predict Conversion to Mild Cognitive Impairment and Dementia? Results From the Hellenic Longitudinal Investigation of Aging and Diet Study1.30Citations (PDF)
6Blood-based biomarkers in mild behavioral impairment: an updated overview2.39Citations (PDF)
7Sleep architecture in Alzheimer’s disease continuum: The deep sleep question
Open Life Sciences, 2025, 20,
1.32Citations (PDF)
8Associations of moderate alcohol intake with cerebrospinal fluid biomarkers of Alzheimer’s disease: data from the ALBION study3.49Citations (PDF)
9Theory of mind deficits in non-fluent primary progressive aphasia
Cortex, 2025, 186, 116-127
2.92Citations (PDF)
10Can Progressive Supranuclear Palsy Be Accurately Identified via MRI with the Use of Visual Rating Scales and Signs?
Biomedicines, 2025, 13, 1009
3.41Citations (PDF)
11Geographic Distribution and Future Projections of Mild Cognitive Impairment and Dementia in Greece: Analysis from 1991 to 2050
Brain Sciences, 2025, 15, 661
2.44Citations (PDF)
12Advances in Genetic Risk Scores for Alzheimer’s Disease and Dementia: A Systematic Review2.90Citations (PDF)
13Depressive symptoms in the entire spectrum of cognitive ageing in Greece: evidence from the Hellenic Longitudinal Investigation of Aging and Diet (HELIAD)2.83Citations (PDF)
14Mild Behavioral Impairment in Parkinson’s Disease: An Updated Review on the Clinical, Genetic, Neuroanatomical, and Pathophysiological Aspects
Medicina (Lithuania), 2024, 60, 115
2.011Citations (PDF)
15Exploring the Genetic Landscape of Mild Behavioral Impairment as an Early Marker of Cognitive Decline: An Updated Review Focusing on Alzheimer’s Disease4.421Citations (PDF)
16Subjective Cognitive Decline and Genetic Propensity for Dementia beyond Apolipoprotein ε4: A Systematic Review2.72Citations (PDF)
17Longitudinal Cognitive Trajectories in Older Adults with Restless Legs Syndrome or Willis–Ekbom Disease
Life, 2024, 14, 430
2.63Citations (PDF)
18Eating Frequency, Timing, and Duration in Relation to Cognitive Performance and Alzheimer Disease Biomarkers in Adults
Journal of Nutrition, 2024, 154, 2167-2175
2.97Citations (PDF)
19Diets
New England Journal of Medicine, 2024, 390, 2098-2106
34.573Citations (PDF)
20Unraveling the Potential Underlying Mechanisms of Mild Behavioral Impairment: Focusing on Amyloid and Tau Pathology
Cells, 2024, 13, 1164
4.613Citations (PDF)
21Reply to Q Zhou and J Chen
Journal of Nutrition, 2024, 154, 2888-2889
2.90Citations (PDF)
22Blood Pressure, Antihypertensive Use, and Late-Life Alzheimer and Non-Alzheimer Dementia Risk
Neurology, 2024, 103,
1.035Citations (PDF)
23The Association between Individual Food Groups, Limbic System White Matter Tracts, and Episodic Memory: Initial Data from the Aiginition Longitudinal Biomarker Investigation of Neurodegeneration (ALBION) Study
Nutrients, 2024, 16, 2766
4.41Citations (PDF)
24Comparison of cerebrospinal fluid and plasma oxidative stress biomarkers0.50Citations (PDF)
25Comparison of cerebrospinal fluid and plasma oxidative stress biomarkers0.51Citations (PDF)
26Longitudinal episodic memory trajectories in older adults with normal cognition
Clinical Neuropsychologist, 2023, 37, 304-321
2.731Citations (PDF)
27Language Differences Among Individuals with Normal Cognition, Amnestic and Non-Amnestic MCI, and Alzheimer’s Disease0.433Citations (PDF)
28Predictive ability of the clock drawing test to detect mild cognitive impairment and dementia over time: Results from the HELIAD study
Clinical Neuropsychologist, 2023, 37, 1651-1668
2.72Citations (PDF)
29The Association of Adherence to the Mediterranean Diet with Depression in Older Adults Longitudinally Taking into Account Cognitive Status: Results from the HELIAD Study
Nutrients, 2023, 15, 359
4.422Citations (PDF)
30Daily Energy Intake Distribution and Cognitive Performance in Non-Demented Individuals
Nutrients, 2023, 15, 673
4.47Citations (PDF)
31Mediterranean diet is associated with a lower probability of prodromal Parkinson's disease and risk for Parkinson's disease/dementia with Lewy bodies: A longitudinal study3.533Citations (PDF)
32Simulating the multicausality of Alzheimer's disease with system dynamics
Alzheimer's and Dementia, 2023, 19, 2633-2654
0.516Citations (PDF)
33A Candidate microRNA Profile for Early Diagnosis of Sporadic Alzheimer’s Disease2.33Citations (PDF)
34Longitudinal Examination of Body Mass Index and Cognitive Function in Older Adults: The HELIAD Study
Nutrients, 2023, 15, 1795
4.418Citations (PDF)
35The science of child and adolescent mental health in Greece: a nationwide systematic review3.116Citations (PDF)
36Subjective Cognitive Decline as a predictor of Frailty in older adults: Hellenic Longitudinal Investigation of Aging and Diet study (HELIAD)1.39Citations (PDF)
37Objective Physical Function in the Alzheimer’s Disease Continuum: Association with Cerebrospinal Fluid Biomarkers in the ALBION Study4.47Citations (PDF)
38Triglycerides and Cognition
Neurology, 2023, 101, 983-984
1.06Citations (PDF)
39Prevalence of Depressive Symptoms in the Whole Spectrum of Cognitive Aging: Findings from the HELIAD Community Study0.50Citations (PDF)
40The factors associated with the presence of psychotic symptoms in the HELIAD Greek community study of older adults
Aging and Mental Health, 2022, 26, 1044-1052
2.93Citations (PDF)
41Parkinsonism and dementia2.122Citations (PDF)
42Trajectories of healthy aging and their association with the Mediterranean diet: The HELIAD Study
Maturitas, 2022, 159, 33-39
2.915Citations (PDF)
43Association between 9p21–23 Locus and Frailty in a Community-Dwelling Greek Population: Results from the Hellenic Longitudinal Investigation of Ageing and Diet3.35Citations (PDF)
44Trajectories of Frailty With Aging: Coordinated Analysis of Five Longitudinal Studies0.130Citations (PDF)
45Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus [RETIRED]
Neurology, 2022, 98, 619-631
1.042Citations (PDF)
46Dietary Inflammatory Index score and prodromal Parkinson's disease incidence: The HELIAD study4.912Citations (PDF)
47New insights into the genetic etiology of Alzheimer’s disease and related dementias
Nature Genetics, 2022, 54, 412-436
25.22,243Citations (PDF)
48Sleep Polygenic Risk Score Is Associated with Cognitive Changes over Time
Genes, 2022, 13, 63
2.512Citations (PDF)
49Sleep Quality and Duration as Determinants of Healthy Aging Trajectories: The HELIAD Study1.315Citations (PDF)
50Vascular burden and genetic risk in association with cognitive performance and dementia in a population-based study1.02Citations (PDF)
51Adherence to the Mediterranean diet and incident frailty: Results from a longitudinal study
Maturitas, 2022, 162, 44-51
2.911Citations (PDF)
52Sex Differences in Frailty Incidence in Greek Community-Dwelling Older People: The HELIAD Study1.36Citations (PDF)
53Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease
JAMA Neurology, 2022, 79, 652
17.695Citations (PDF)
54Dietary and Nutrient Patterns and Brain MRI Biomarkers in Dementia-Free Adults
Nutrients, 2022, 14, 2345
4.426Citations (PDF)
55Nutrition state of science and dementia prevention: recommendations of the Nutrition for Dementia Prevention Working Group
The Lancet Healthy Longevity, 2022, 3, e501-e512
10.393Citations (PDF)
56Longitudinal trajectories and normative language standards in older adults with normal cognitive status.
Neuropsychology, 2022, 36, 626-639
1.618Citations (PDF)
57The Longitudinal Association of Lifestyle with Cognitive Health and Dementia Risk: Findings from the HELIAD Study
Nutrients, 2022, 14, 2818
4.422Citations (PDF)
58Objective and Subjective Measurements of Motor Function: Results from the HELIAD Study3.31Citations (PDF)
59Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort2.615Citations (PDF)
60Population Attributable Fractions for Modifiable Risk Factors of Incident Dementia in Cognitively Normal and Mild Cognitively Impaired Older Adults: Data from Two Cohort Studies2.66Citations (PDF)
61Initial Data and a Clinical Diagnosis Transition for the Aiginition Longitudinal Biomarker Investigation of Neurodegeneration (ALBION) Study
Medicina (Lithuania), 2022, 58, 1179
2.011Citations (PDF)
62Cognitive trajectories preluding the imminent onset of Alzheimer’s disease dementia in individuals with normal cognition: results from the HELIAD cohort2.719Citations (PDF)
63Qualitative Verbal Fluency Components as Prognostic Factors for Developing Alzheimer’s Dementia and Mild Cognitive Impairment: Results from the Population-Based HELIAD Cohort
Medicina (Lithuania), 2022, 58, 1814
2.014Citations (PDF)
64Frailty and Prodromal Parkinson’s Disease: Results From the HELIAD Study3.428Citations (PDF)
65Association Between Sleep Disturbances and Frailty: Evidence From a Population-Based Study2.462Citations (PDF)
66Plasma GSH levels and Alzheimer's disease. A prospective approach.: Results from the HELIAD study3.750Citations (PDF)
67Biomarker counseling, disclosure of diagnosis and follow‐up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey2.226Citations (PDF)
68DHA intake relates to better cerebrovascular and neurodegeneration neuroimaging phenotypes in middle-aged adults at increased genetic risk of Alzheimer disease4.727Citations (PDF)
69Incidence of mild cognitive impairment in the elderly population in Greece: results from the HELIAD study2.711Citations (PDF)
70Mediterranean diet and risk for dementia and cognitive decline in a Mediterranean population2.963Citations (PDF)
71Dystonia assessment in children with cerebral palsy and periventricular leukomalacia1.813Citations (PDF)
72Late life psychotic features in prodromal Parkinson's disease2.68Citations (PDF)
73Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores13.7293Citations (PDF)
74Mind Diet Adherence and Cognitive Performance in the Framingham Heart Study2.658Citations (PDF)
75Dementia Incidence in the Elderly Population of Greece1.316Citations (PDF)
76Pesticide Use and its Effects on Daily Functioning among Elderly Farmers0.22Citations (PDF)
77Population attributable fractions for modifiable risk factors of dementia in cognitively normal and MCI populations: Data from two countries0.50Citations (PDF)
78Association of the Polygenic Risk Score With the Probability of Prodromal Parkinson’s Disease in Older Adults3.414Citations (PDF)
79State of science in nutrition clinical trials for dementia prevention0.52Citations (PDF)
80Prevalence and Risk Factors of Frailty in a Community-Dwelling Population: The HELIAD Study1.937Citations (PDF)
81Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance
Alzheimer's and Dementia, 2020, 16, 1305-1311
0.51,478Citations (PDF)
82Exploring the association between subjective cognitive decline and frailty: the Hellenic Longitudinal Investigation of Aging and Diet Study (HELIAD)
Aging and Mental Health, 2020, 24, 137-147
2.933Citations (PDF)
83Malnutrition in older adults: Correlations with social, diet-related, and neuropsychological factors
Nutrition, 2020, 71, 110640
2.756Citations (PDF)
84Education and the moderating roles of age, sex, ethnicity and apolipoprotein epsilon 4 on the risk of cognitive impairment3.414Citations (PDF)
85Nighttime Blood Pressure Interacts with APOE Genotype to Increase the Risk of Incident Dementia of the Alzheimer’s Type in Hispanics2.64Citations (PDF)
86Type 2 Diabetes and Mediterranean Diet in Older Adults: a Brief Review of the Evidence
Current Geriatrics Reports, 2020, 9, 237-241
0.50Citations (PDF)
87Does parity matter in women’s risk of dementia? A COSMIC collaboration cohort study
BMC Medicine, 2020, 18,
7.151Citations (PDF)
88APOE ε4 and the Influence of Sex, Age, Vascular Risk Factors, and Ethnicity on Cognitive Decline3.444Citations (PDF)
89A Prospective Validation of the Updated Movement Disorders Society Research Criteria for Prodromal Parkinson's Disease
Movement Disorders, 2020, 35, 1802-1809
4.623Citations (PDF)
90Prevalence of Mild Cognitive Impairment in the Elderly Population in Greece: Results From the HELIAD Study1.343Citations (PDF)
91Pesticide exposure and cognitive function: Results from the Hellenic Longitudinal Investigation of Aging and Diet (HELIAD)
Environmental Research, 2019, 177, 108632
7.729Citations (PDF)
92Motor function and the probability of prodromal Parkinson's disease in older adults
Movement Disorders, 2019, 34, 1345-1353
4.623Citations (PDF)
93Determinants of cognitive performance and decline in 20 diverse ethno-regional groups: A COSMIC collaboration cohort study
PLoS Medicine, 2019, 16, e1002853
8.0129Citations (PDF)
94Apolipoprotein ε4 allele is associated with frailty syndrome: results from the hellenic longitudinal investigation of ageing and diet study
Age and Ageing, 2019, 48, 917-921
1.825Citations (PDF)
95Aiginition Longitudinal Biomarker Investigation Of Neurodegeneration (ALBION): study design, cohort description, and preliminary data
Postgraduate Medicine, 2019, 131, 501-508
2.516Citations (PDF)
96The relationship between environmental factors and different Parkinson's disease subtypes in Greece: Data analysis of the Hellenic Biobank of Parkinson's disease2.623Citations (PDF)
97Prevalence and determinants of subjective cognitive decline in a representative Greek elderly population2.240Citations (PDF)
98Associations between frailty and menopause-related factors: findings from the HELIAD study
Maturitas, 2019, 124, 147-148
2.94Citations (PDF)
99Higher probability of prodromal Parkinson disease is related to lower cognitive performance
Neurology, 2019, 92,
1.039Citations (PDF)
100Food Consumption and Frailty Syndrome: Results From the Hellenic Longitudinal Investigation of Aging and Diet Study2.41Citations (PDF)
101Mechanisms underlying resilience in ageing
Nature Reviews Neuroscience, 2019, 20, 246-246
20.840Citations (PDF)
102Associations between sleep and obesity indices in older adults: results from the HELIAD study2.715Citations (PDF)
103Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease
Movement Disorders, 2019, 34, 48-57
4.6188Citations (PDF)
104Sleep and subjective cognitive decline in cognitively healthy elderly: Results from two cohorts3.882Citations (PDF)
105The Cretan Aging Cohort: Cohort Description and Burden of Dementia and Mild Cognitive Impairment2.030Citations (PDF)
106The Association of Sedentary Behaviour and Cognitive Function in People Without Dementia: A Coordinated Analysis Across Five Cohort Studies from COSMIC
Sports Medicine, 2019, 50, 403-413
6.256Citations (PDF)
107Associations between the Mediterranean diet and sleep in the elderly0.73Citations (PDF)
108History of induced abortions and frailty in older Greek women: results from the HELIAD study
European Geriatric Medicine, 2018, 9, 301-310
2.410Citations (PDF)
109Adherence to Mediterranean Diet and Frailty2.486Citations (PDF)
110Self-reported fatigue as a risk index for dementia diagnosis
European Geriatric Medicine, 2018, 9, 211-217
2.47Citations (PDF)
111Dementia Prevalence in Greece1.368Citations (PDF)
112Dietary Patterns, Physical Activity, Sleep, and Risk for Dementia and Cognitive Decline
Current Nutrition Reports, 2018, 7, 335-345
4.881Citations (PDF)
113Mediterranean Lifestyle in Relation to Cognitive Health: Results from the HELIAD Study
Nutrients, 2018, 10, 1557
4.456Citations (PDF)
114P3‐622: BMI AND COGNITIVE PERFORMANCE IN OLDER ADULTS0.50Citations (PDF)
115Mediterranean diet adherence and rate of cerebral Aβ-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing5.283Citations (PDF)
116Associations between the mediterranean diet and sleep in older adults: Results from the hellenic longitudinal investigation of aging and diet study1.655Citations (PDF)
117Nutrition and prevention of cognitive impairment
Lancet Neurology, The, 2018, 17, 1006-1015
17.9545Citations (PDF)
118Weight Loss Maintenance: Have We Missed the Brain?
Brain Sciences, 2018, 8, 174
2.415Citations (PDF)
119Eating habits and behaviors of older people: Where are we now and where should we go?
Maturitas, 2018, 114, 14-21
2.978Citations (PDF)
120Differential effects of completed and incomplete pregnancies on the risk of Alzheimer disease
Neurology, 2018, 91,
1.094Citations (PDF)
121Sleep quality and duration in relation to memory in the elderly: Initial results from the Hellenic Longitudinal Investigation of Aging and Diet1.660Citations (PDF)
122Circulating inflammatory biomarkers in relation to brain structural measurements in a non-demented elderly population4.596Citations (PDF)
123Frailty and nutrition: From epidemiological and clinical evidence to potential mechanisms9.1153Citations (PDF)
124Mediterranean diet and cognitive health: Initial results from the Hellenic Longitudinal Investigation of Ageing and Diet
PLoS ONE, 2017, 12, e0182048
2.3257Citations (PDF)
125Age-related cognitive decline and associations with sex, education and apolipoprotein E genotype across ethnocultural groups and geographic regions: a collaborative cohort study
PLoS Medicine, 2017, 14, e1002261
8.0174Citations (PDF)
126Association between frequency of sleep medication use and brain morphology (P3.058)
Neurology, 2017, 88,
1.00Citations (PDF)
127Daytime somnolence as an early sign of cognitive decline in a community‐based study of older people2.240Citations (PDF)
128P4‐153: Subjective Cognitive Decline and Progression to Dementia Due to AD and Non‐AD in Memory Clinic and Community‐Based Cohorts0.51Citations (PDF)
129O1‐08‐01: Mediterranean DIET is Associated with Slower Rate of Hippocampal Atrophy: a Longitudinal Study in Cognitively Normal Older Adults0.57Citations (PDF)
130Self-Reported Sleep Disordered Breathing as Risk Factor for Mortality in the Elderly1.67Citations (PDF)
131Is late‐onset Alzheimer's disease really a disease of midlife?4.8102Citations (PDF)
132Data from a cross-sectional study on Apolipoprotein E ( APOE -ε4) and snoring/sleep apnea in non-demented older adults
Data in Brief, 2015, 5, 351-353
1.17Citations (PDF)
133New Perspectives on Alzheimer’s Disease and Nutrition
Journal of Alzheimer's Disease, 2015, 46, 1111-1127
2.664Citations (PDF)
134Restless Legs Syndrome in the Darkness of Dementia
Sleep, 2015, 38, 333-334
0.96Citations (PDF)
135Mediterranean diet and leukocyte telomere length in a multi-ethnic elderly population
Age, 2015, 37,
3.069Citations (PDF)
136Mediterranean diet and brain structure in a multiethnic elderly cohort
Neurology, 2015, 85, 1744-1751
1.0227Citations (PDF)
137Medicare Utilization and Expenditures Around Incident Dementia in a Multiethnic Cohort3.460Citations (PDF)
138Examining the association between Apolipoprotein E (APOE) and self-reported sleep disturbances in non-demented older adults
Neuroscience Letters, 2015, 606, 72-76
1.914Citations (PDF)
139Cognitive health and Mediterranean Diet: Just diet or lifestyle pattern?
Ageing Research Reviews, 2015, 20, 74-78
11.6125Citations (PDF)
140Self-reported sleep problems and incidence of dementia (P2.173)
Neurology, 2015, 84,
1.00Citations (PDF)
141A New Algorithm for Predicting Time to Disease Endpoints in Alzheimer's Disease Patients2.619Citations (PDF)
142P3‐323: DIETARY TOTAL ANTIOXIDANT CAPACITY AND RISK OF DEMENTIA AND MILD COGNITIVE IMPAIRMENTS0.50Citations (PDF)
143The Association between a Mediterranean-Style Diet and Kidney Function in the Northern Manhattan Study Cohort4.2133Citations (PDF)
144Reply
Annals of Neurology, 2014, 75, 614-614
6.61Citations (PDF)
145Vitamin D and Cognition: An Update of the Current Evidence2.654Citations (PDF)
146Mediterranean diet and carotid atherosclerosis in the Northern Manhattan Study
Atherosclerosis, 2014, 234, 303-310
1.560Citations (PDF)
147Alcohol intake and brain structure in a multiethnic elderly cohort
Clinical Nutrition, 2014, 33, 662-667
5.355Citations (PDF)
148Serum IgG Antibody Levels to Periodontal Microbiota Are Associated with Incident Alzheimer Disease
PLoS ONE, 2014, 9, e114959
2.3190Citations (PDF)
149P3‐342: MEDITERRANEAN DIET AND LEUKOCYTE TELOMERE LENGTH IN A MULTI‐ETHNIC ELDERLY POPULATION0.52Citations (PDF)
150Dietary patterns and cognitive decline in an Australian study of ageing
Molecular Psychiatry, 2014, 20, 860-866
7.8130Citations (PDF)
151Lessons from Epidemiologic Research about Risk Factors, Modifiers, and Progression of Late Onset Alzheimer's Disease in New York City at Columbia University Medical Center
Journal of Alzheimer's Disease, 2013, 33, S447-S455
2.69Citations (PDF)
152Mediterranean diet, stroke, cognitive impairment, and depression: A meta‐analysis
Annals of Neurology, 2013, 74, 580-591
6.6739Citations (PDF)
153Relationship of Mediterranean Diet and Caloric Intake to Phenoconversion in Huntington Disease
JAMA Neurology, 2013, ,
17.641Citations (PDF)
154Poor Oral Health as a Chronic, Potentially Modifiable Dementia Risk Factor: Review of the Literature4.4122Citations (PDF)
155The paradox of overnutrition in aging and cognition4.022Citations (PDF)
156The Differential Impact of Unique Behavioral and Psychological Symptoms for the Dementia Caregiver: How and Why Do Patients' Individual Symptom Clusters Impact Caregiver Depressive Symptoms?1.755Citations (PDF)
157Diet and Neuroimaging Markers of Cerebrovascular Disease4.811Citations (PDF)
158Does Mediterranean Diet Modify Phenoconversion in Huntington's Disease (HD) ? (P07.211)
Neurology, 2013, 80,
1.00Citations (PDF)
159Adherence to a Mediterranean diet and Alzheimer’s disease risk in an Australian population
Translational Psychiatry, 2012, 2, e164-e164
5.2169Citations (PDF)
160Mediterranean Diet and White Matter Hyperintensity Volume in the Northern Manhattan Study
Archives of Neurology, 2012, 69, 251
6.8128Citations (PDF)
161Seizures and Epilepsy in Alzheimer's Disease5.0217Citations (PDF)
162Nutrient intake and plasma β-amyloid
Neurology, 2012, 78, 1832-1840
1.077Citations (PDF)
163THAP1 mutations and dystonia phenotypes: Genotype phenotype correlations
Movement Disorders, 2012, 27, 1290-1294
4.6135Citations (PDF)
164Seizures in Alzheimer Disease: Clinical and Epidemiological Data
Epilepsy Currents, 2012, 12, 184-187
3.1141Citations (PDF)
165White matter hyperintensity volume and impaired mobility among older adults
Journal of Neurology, 2012, 260, 884-890
3.427Citations (PDF)
166Physical Activity and Alzheimer Disease Course1.784Citations (PDF)
167Mediterranean diet and magnetic resonance imaging–assessed cerebrovascular disease
Annals of Neurology, 2011, 69, 257-268
6.6116Citations (PDF)
168Reply
Annals of Neurology, 2011, 70, 1006-1007
6.60Citations (PDF)
169Dietary Inflammation Factor Rating System and Risk of Alzheimer Disease in Elders1.311Citations (PDF)
170Utilization of Antihypertensives, Antidepressants, Antipsychotics, and Hormones in Alzheimer Disease1.38Citations (PDF)
171Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study4.7212Citations (PDF)
172Plasma β-Amyloid and Cognitive Decline6.881Citations (PDF)
173Food Combination and Alzheimer Disease Risk
Archives of Neurology, 2010, 67, 699
6.8373Citations (PDF)
174Longitudinal Medication Usage in Alzheimer Disease Patients1.312Citations (PDF)
175Mediterranean Diet, Inflammatory and Metabolic Biomarkers, and Risk of Alzheimer's Disease2.6230Citations (PDF)
176Physical Activity, Diet, and Risk of Alzheimer Disease16.5793Citations (PDF)
177Extrapyramidal Signs Before and After Diagnosis of Incident Alzheimer Disease in a Prospective Population Study6.869Citations (PDF)
178Contribution of Vascular Risk Factors to the Progression in Alzheimer Disease6.8295Citations (PDF)
179Seizures in Alzheimer Disease6.8288Citations (PDF)
180Periodontitis is associated with cognitive impairment among older adults: analysis of NHANES-III6.3285Citations (PDF)
181Adherence to a Mediterranean Diet, Cognitive Decline, and Risk of Dementia16.5691Citations (PDF)
182Mediterranean Diet and Mild Cognitive Impairment6.8605Citations (PDF)
183Bridging from clinical endpoints to estimates of treatment value for external decision makers3.114Citations (PDF)
184Chapter 7 Application of Pet Imaging to Diagnosis of Alzheimer's Disease and Mild Cognitive Impairment13.130Citations (PDF)
185Randomized double‐blind placebo‐controlled donepezil augmentation in antidepressant‐treated elderly patients with depression and cognitive impairment: a pilot study2.252Citations (PDF)
186A forward application of age associated gray and white matter networks
Human Brain Mapping, 2008, 29, 1139-1146
3.526Citations (PDF)
187Multivariate and Univariate Analysis of Continuous Arterial Spin Labeling Perfusion MRI in Alzheimer's Disease4.7176Citations (PDF)
188The Effects of Patient Function and Dependence on Costs of Care in Alzheimer's Disease2.962Citations (PDF)
189Patient's age modifies the impact of the proposed predictors of sustained virological response in chronic hepatitis C patients treated with PEG-interferon plus ribavirin2.79Citations (PDF)
190Home Health and Informal Care Utilization and Costs Over Time in Alzheimer's Disease1.344Citations (PDF)
191The Relation of Patient Dependence to Home Health Aide Use in Alzheimer's Disease3.420Citations (PDF)
192Survival in Alzheimer disease
Neurology, 2008, 71, 1489-1495
1.0221Citations (PDF)
193APOE ε4 allele predicts faster cognitive decline in mild Alzheimer disease
Neurology, 2008, 70, 1842-1849
1.0207Citations (PDF)
194Measuring Cerebral Atrophy and White Matter Hyperintensity Burden to Predict the Rate of Cognitive Decline in Alzheimer Disease6.8152Citations (PDF)
195Distinct Pools of β-Amyloid in Alzheimer Disease–Affected Brain6.895Citations (PDF)
196Disruptive Behavior as a Predictor in Alzheimer Disease
Archives of Neurology, 2007, 64, 1755
6.8159Citations (PDF)
197Impairment of nonverbal recognition in Alzheimer disease: A PET O-15 study
Neurology, 2007, 69, 32-41
1.09Citations (PDF)
198Invited Commentary: Lipoproteins and Dementia--Is It the Apolipoprotein A-I?3.314Citations (PDF)
199Leisure Activity and Cognitive Decline in Incident Alzheimer Disease
Archives of Neurology, 2007, 64, 1749
6.898Citations (PDF)
200Mediterranean diet and Alzheimer disease mortality
Neurology, 2007, 69, 1084-1093
1.0315Citations (PDF)
201Paraoxonase 1 gene polymorphisms in patients with osteonecrosis of the femoral head with and without cerebral white matter lesions
Journal of Orthopaedic Research, 2007, 25, 1087-1093
2.429Citations (PDF)
202A Randomized, Double-Blind, Placebo-Controlled Trial of Donepezil to Improve Memory in Epilepsy
Epilepsia, 2007, 48, 1283-1291
4.446Citations (PDF)
203Diet and Alzheimer’s disease4.4117Citations (PDF)
204Upregulation of RAGE and its ligands in proliferative retinal disease
Experimental Eye Research, 2006, 82, 807-815
2.5105Citations (PDF)
205Verbal Fluency Predicts Mortality in Alzheimer Disease1.146Citations (PDF)
206The Progression of Cognition, Psychiatric Symptoms, and Functional Abilities in Dementia With Lewy Bodies and Alzheimer Disease
Archives of Neurology, 2006, 63, 1450
6.896Citations (PDF)
207Clinical Characteristics and Longitudinal Changes of Informal Cost of Alzheimer's Disease in the Community2.982Citations (PDF)
208Imaging studies and APOE genotype in persons at risk for Alzheimer’s disease5.336Citations (PDF)
209Association of α-synuclein Rep1 polymorphism and Parkinson's disease: Influence of Rep1 on age at onset
Movement Disorders, 2006, 21, 534-539
4.651Citations (PDF)
210Mediterranean diet and risk for Alzheimer's disease
Annals of Neurology, 2006, 59, 912-921
6.61,041Citations (PDF)
211Reply
Annals of Neurology, 2006, 60, 621-621
6.629Citations (PDF)
212Single-dose Levodopa Administration and Aging Independently Disrupt Time Production2.230Citations (PDF)
213An Observational Study of Cognitive Impairment in Amyotrophic Lateral Sclerosis
Archives of Neurology, 2006, 63, 345
6.8143Citations (PDF)
214Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease
Neurology, 2006, 67, 998-1005
1.0113Citations (PDF)
215Mediterranean Diet, Alzheimer Disease, and Vascular Mediation
Archives of Neurology, 2006, 63, 1709
6.8363Citations (PDF)
216Clinical features associated with costs in early AD
Neurology, 2006, 66, 1021-1028
1.076Citations (PDF)
217Depressive Symptoms in Alzheimer's Disease: Natural Course and Temporal Relation to Function and Cognitive Status2.991Citations (PDF)
218An event-related fMRI study of the neural networks underlying the encoding, maintenance, and retrieval phase in a delayed-match-to-sample task
Cognitive Brain Research, 2005, 23, 207-220
4.0126Citations (PDF)
219CA 19-9 Levels Predict Results of Staging Laparoscopy in Pancreatic Cancer1.790Citations (PDF)
220IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury
Neurology, 2005, 65, 1077-1082
1.069Citations (PDF)
221Motor signs predict poor outcomes in Alzheimer disease
Neurology, 2005, 64, 1696-1703
1.0195Citations (PDF)
222Education and rates of cognitive decline in incident Alzheimer's disease6.3315Citations (PDF)
223Predictive Utility of Apolipoprotein E Genotype for Alzheimer Disease in Outpatients With Mild Cognitive Impairment6.8109Citations (PDF)
224Delusions and Hallucinations Are Associated With Worse Outcome in Alzheimer Disease6.8315Citations (PDF)
225Brain Networks Associated with Cognitive Reserve in Healthy Young and Old Adults
Cerebral Cortex, 2005, 15, 394-402
2.8375Citations (PDF)
226PET Network Abnormalities and Cognitive Decline in Patients with Mild Cognitive Impairment
Neuropsychopharmacology, 2005, 31, 1327-1334
5.435Citations (PDF)
227Identification and Differential Vulnerability of a Neural Network in Sleep Deprivation
Cerebral Cortex, 2004, 14, 496-502
2.896Citations (PDF)
228Motor signs during the course of Alzheimer disease
Neurology, 2004, 63, 975-982
1.0233Citations (PDF)
229Frontotemporal degenerative dementias1.03Citations (PDF)
230An event-related fMRI study of the neurobehavioral impact of sleep deprivation on performance of a delayed-match-to-sample task
Cognitive Brain Research, 2004, 18, 306-321
4.0157Citations (PDF)
231Cognitive reserve: Implications for diagnosis and prevention of Alzheimer’s disease4.4217Citations (PDF)
232Frontotemporal degenerative dementias1.01Citations (PDF)
233Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance
NeuroImage, 2004, 23, 35-45
4.4103Citations (PDF)
234Imaging cognitive reserve2.07Citations (PDF)
235Cognitive Reserve–Mediated Modulation of Positron Emission Tomographic Activations During Memory Tasks in Alzheimer Disease
Archives of Neurology, 2004, 61, 73
6.855Citations (PDF)
236Altered PET Functional Brain Responses in Cognitively Intact Elderly Persons at Risk for Alzheimer Disease (Carriers of the  4 Allele)1.723Citations (PDF)
237Altered PET Functional Brain Responses in Cognitively Intact Elderly Persons at Risk for Alzheimer Disease (Carriers of the ε4 Allele)1.718Citations (PDF)
238Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects
NeuroImage, 2003, 19, 1215-1227
4.4144Citations (PDF)
239Cognitive Reserve and Lifestyle1.0732Citations (PDF)
240Risk factors for fever in the neurologic intensive care unit
Neurology, 2003, 60, 837-841
1.0188Citations (PDF)
241Association of Life Activities With Cerebral Blood Flow in Alzheimer Disease
Archives of Neurology, 2003, 60, 359
6.8251Citations (PDF)
242Premorbid weight, body mass, and varsity athletics in ALS
Neurology, 2003, 61, 1024-1025
1.08Citations (PDF)
243Association between the APOE genotype and psychopathologic symptoms in Alzheimer’s disease
Neurology, 2002, 58, 1182-1188
1.0104Citations (PDF)
244Cortical Basal Ganglionic Degeneration0.53Citations (PDF)
245Oculogyric-like crises in a 92-year-old woman with vascular Parkinsonism
Movement Disorders, 2001, 16, 353-355
4.67Citations (PDF)
246Clinical trial of an air-circulating cooling blanket for fever control in critically ill neurologic patients
Neurology, 2001, 56, 292-298
1.096Citations (PDF)
247Influence of leisure activity on the incidence of Alzheimer’s Disease
Neurology, 2001, 57, 2236-2242
1.0724Citations (PDF)
248Assessing mental flexibility in the older population with low levels of education2.70Citations (PDF)
249The duality of disease: the Alzheimer’s disease dilemma through the lens of nosos and asthenia
Brain, 0, 148, 3425-3427
8.40Citations (PDF)
250Emotional and instrumental social support and older adults’ depressive symptoms: collaborative individual participant data meta-analysis of 11 population-based studies of aging3.32Citations (PDF)
251Finger tapping and paratonia assessment in older adults with and without Mild cognitive impairment, motor-cognitive correlations1.90Citations (PDF)
252Sleep Pattern Trajectories and Incident Mild Cognitive Impairment and Dementia: Results from the HELIAD Study
Clinical Gerontologist, 0, 48, 1140-1155
2.61Citations (PDF)
253Resting EEG partial coherence demonstrates increased <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" altimg="si34.svg"> <mml:mrow> <mml:mrow> <mml:mi mathvariant="bold-italic">γ</mml:mi> </mml:mrow> </mml:mrow> </mml:math> range central functional connectivity in amnestic mild cognitive impairment
Brain Research, 0, 1867, 149973
2.50Citations (PDF)
254Longitudinal Association of a Polygenic Risk Score for Plasma T-Tau With Incident Alzheimer Dementia and Mild Cognitive Impairment
Neurology, 0, 105,
1.00Citations (PDF)
255Association between adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet and cerebrospinal fluid Alzheimer’s disease biomarkers in middle-life individuals without dementia: the ALBION study
Nutritional Neuroscience, 0, 29, 753-763
3.60Citations (PDF)
256Mediterranean Diet and the Risk of Stroke Subtypes in Women
0, 2,
0Citations (PDF)
257Sex-specific associations between reproductive history and late-life cognitive outcomes1.00Citations (PDF)